# One Versus Twice Daily Administration of Multiple Cardiovascular Agents in Patients With Ischemic Heart Disease

> **NCT04148820** · PHASE4 · UNKNOWN · sponsor: **University of Roma La Sapienza** · enrollment: 100 (estimated)

## Conditions studied

- Ischemic Heart Disease

## Interventions

- **DRUG:** Aspirin, Atorvastatin, Perindopril

## Key facts

- **NCT ID:** NCT04148820
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-11-01
- **Primary completion:** 2021-10-31
- **Final completion:** 2021-10-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04148820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04148820, "One Versus Twice Daily Administration of Multiple Cardiovascular Agents in Patients With Ischemic Heart Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04148820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*